Research programme: malaria vaccine - Novavax/CPL Biologicals/ICGEBAlternative Names: Falciparum malaria vaccine - Novavax/CPL Biologicals; Malaria VLP vaccine - Novavax/CPL Biologicals
Latest Information Update: 16 Jul 2016
At a glance
- Originator CPL Biologicals; International Centre for Genetic Engineering and Biotechnology; Novavax
- Class Parasitic vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Falciparum malaria
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Falciparum-malaria in India
- 16 Jul 2012 Early research in Falciparum malaria in India (unspecified route)